GB202012954D0 - Etoposide toniribate formulation - Google Patents

Etoposide toniribate formulation

Info

Publication number
GB202012954D0
GB202012954D0 GBGB2012954.0A GB202012954A GB202012954D0 GB 202012954 D0 GB202012954 D0 GB 202012954D0 GB 202012954 A GB202012954 A GB 202012954A GB 202012954 D0 GB202012954 D0 GB 202012954D0
Authority
GB
United Kingdom
Prior art keywords
toniribate
etoposide
formulation
toniribate formulation
etoposide toniribate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2012954.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guggi Davide
Original Assignee
Guggi Davide
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guggi Davide filed Critical Guggi Davide
Priority to GBGB2012954.0A priority Critical patent/GB202012954D0/en
Publication of GB202012954D0 publication Critical patent/GB202012954D0/en
Priority to PCT/EP2021/073034 priority patent/WO2022038226A1/en
Priority to CA3189720A priority patent/CA3189720A1/en
Priority to JP2023512354A priority patent/JP2023539154A/en
Priority to AU2021327164A priority patent/AU2021327164A1/en
Priority to US18/022,353 priority patent/US20230398069A1/en
Priority to EP21765900.2A priority patent/EP4199933A1/en
Priority to KR1020237009044A priority patent/KR20230131815A/en
Ceased legal-status Critical Current

Links

GBGB2012954.0A 2020-08-19 2020-08-19 Etoposide toniribate formulation Ceased GB202012954D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB2012954.0A GB202012954D0 (en) 2020-08-19 2020-08-19 Etoposide toniribate formulation
PCT/EP2021/073034 WO2022038226A1 (en) 2020-08-19 2021-08-19 Etoposide toniribate formulation
CA3189720A CA3189720A1 (en) 2020-08-19 2021-08-19 Etoposide toniribate formulation
JP2023512354A JP2023539154A (en) 2020-08-19 2021-08-19 Etoposide tonilibate formulation
AU2021327164A AU2021327164A1 (en) 2020-08-19 2021-08-19 Etoposide toniribate formulation
US18/022,353 US20230398069A1 (en) 2020-08-19 2021-08-19 Etoposide toniribate formulation
EP21765900.2A EP4199933A1 (en) 2020-08-19 2021-08-19 Etoposide toniribate formulation
KR1020237009044A KR20230131815A (en) 2020-08-19 2021-08-19 Etoposide Tony Libate Formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2012954.0A GB202012954D0 (en) 2020-08-19 2020-08-19 Etoposide toniribate formulation

Publications (1)

Publication Number Publication Date
GB202012954D0 true GB202012954D0 (en) 2020-09-30

Family

ID=72615484

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2012954.0A Ceased GB202012954D0 (en) 2020-08-19 2020-08-19 Etoposide toniribate formulation

Country Status (1)

Country Link
GB (1) GB202012954D0 (en)

Similar Documents

Publication Publication Date Title
IL284688A (en) Formulation
GB202007546D0 (en) Formulation
GB202012956D0 (en) Etoposide toniribate formulation
GB202012954D0 (en) Etoposide toniribate formulation
GB201909584D0 (en) Etoposide toniribate formulation
GB201909594D0 (en) Etoposide toniribate formulation
GB2595300B (en) Novel Formulation
GB2595453B (en) Novel Formulation
GB2599912B (en) New formulation
GB202007620D0 (en) Novel formulation
IL307849A (en) Sotorasib formulation
IL308046A (en) Alpelisib formulation
GB202108165D0 (en) Formulation
GB202107439D0 (en) Formulation
GB202107203D0 (en) Formulation
PL4138585T3 (en) Aerosolisable formulation
GB202103970D0 (en) Formulation
GB202102636D0 (en) Formulation
GB202102408D0 (en) Formulation
GB202016274D0 (en) Formulation
GB202010573D0 (en) Formulation
GB202005340D0 (en) Formulation
GB202003048D0 (en) Formulation
IL305977A (en) Formulation comprising ceralasertib
GB202115303D0 (en) New formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)